Jinling Pharmaceutical Company Limited (SHE:000919)
China · Delayed Price · Currency is CNY 6.50
+0.07 (1.09%)
Sep 30, 2026, 3:04 PM CST
SHE:000919 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 3,181 | 3,197 | 3,281 | 3,194 | 2,671 | 2,809 |
Revenue Growth | 0.40% | -2.56% | 2.74% | 19.58% | -4.91% | 12.18% |
Gross Profit Gross Profit Growth | 709.33 | 665.96 | 605.17 | 637.06 | 528.55 | 628.17 |
Operating Income Operating Income Growth | 50.76 | 24.96 | 25.31 | 80.84 | 51.03 | 169.24 |
Net Income Net Income Growth | 55.96 | 53.91 | 40.41 | 106.19 | 105.28 | 120.63 |
Earnings Per Share EPS Growth | 0.09 | 0.09 | 0.07 | 0.21 | 0.21 | 0.24 |
EPS Growth | 71.67% | 27.13% | -67.63% | 0.86% | -12.70% | 85.22% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Medicine Production and Sales Medicine Production and Sales Growth | 1,426 | 1,495 | 1,493 | 1,554 | 1,410 | 1,478 |
Medical Services Medical Services Growth | 1,703 | 1,649 | 1,740 | 1,570 | 1,214 | 1,288 |
Others Others Growth | 52.21 | 53.65 | 48.22 | 69.79 | 46.95 | 42.38 |
Total Total Growth | 3,181 | 3,197 | 3,281 | 3,194 | 2,671 | 2,809 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 2,908 | 2,849 | 2,642 | 2,119 | 1,837 | 1,503 |
Total Debt Total Debt Growth | 192.02 | 191.82 | 189.21 | 41.67 | 5.3 | 16.66 |
Net Cash (Debt) Net Cash Growth | 2,716 | 2,658 | 2,453 | 2,077 | 1,832 | 1,486 |
Net Cash Growth | 9.75% | 8.34% | 18.08% | 13.39% | 23.26% | 12.85% |
Net Cash Per Share Net Cash Per Share Growth | 4.37 | 4.27 | 4.14 | 4.12 | 3.64 | 2.95 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 405.76 | 174.21 | 154.19 | 212.02 | 260.59 | 292.03 |
Capital Expenditures CapEx Growth | -131.77 | -157.87 | -201.63 | -237.88 | -309.64 | -162.76 |
Free Cash Flow Free Cash Flow Growth | 273.99 | 16.34 | -47.44 | -25.85 | -49.05 | 129.26 |
Free Cash Flow Growth | 1152.01% | - | - | - | - | 544.48% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 22.30% | 20.83% | 18.44% | 19.95% | 19.79% | 22.36% |
Operating Margin | 1.60% | 0.78% | 0.77% | 2.53% | 1.91% | 6.02% |
Pretax Margin | 2.32% | 2.04% | 1.22% | 4.64% | 4.78% | 6.94% |
Profit Margin | 1.76% | 1.69% | 1.23% | 3.33% | 3.94% | 4.29% |
FCF Margin | 8.61% | 0.51% | -1.45% | -0.81% | -1.84% | 4.60% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.100 | 0.100 | 0.100 | 0.100 | 0.100 | 0.100 |
Dividend Per Share Growth | 0% | 0% | 0% | 0% | 0% | 0% |
Dividend Yield | 1.54% | 1.28% | 1.57% | 1.33% | 1.36% | 1.41% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 72.22 | 91.71 | 101.56 | 37.88 | 37.67 | 31.96 |
Forward PE | - | 20.24 | 20.24 | 20.24 | 20.24 | 20.24 |
P/FCF Ratio | 14.75 | 302.55 | - | - | - | 29.83 |
PS Ratio | 1.27 | 1.55 | 1.25 | 1.26 | 1.49 | 1.37 |